Logo der Universität Basel

Research Database / FORSCHUNGSDATENBANK 
PRINTDOC
 
Publication 4514961 | Verified
 

Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Survival of Second-Line Biologics in Psoriasis: The British BADBIR Registry Data Informs Daily Practice
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4514961
Author(s) Navarini, Alexander A.; French, Lars E.
Author(s) at UniBasel Navarini, Alexander
Year 2018
Title Survival of Second-Line Biologics in Psoriasis: The British BADBIR Registry Data Informs Daily Practice
Journal The Journal of Investigative Dermatology
Volume 138
Number 4
Pages / Article-Number 726-728
Mesh terms Biological Products; Biological Therapy; Cohort Studies; Dermatologists; Humans; Psoriasis; Quality of Life; Registries
Abstract Psoriasis is one of the most chronic diseases in dermatology. Only a small percentage of patients ever experience relapse-free survival. The constant presence of plaques and comorbidities that affect the cardiovascular system, joints, and other organs greatly impair patients' quality of life. In addition, the life expectancy of psoriatic patients is shortened by several years. Hence, long-term and ideally systemic treatment with minimal adverse effects may be warranted.
Publisher ELSEVIER SCIENCE INC
ISSN/ISBN 1523-1747
edoc-URL https://edoc.unibas.ch/72198/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.jid.2018.02.008
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/29579453
ISI-Number WOS:000428135400006
Document type (ISI) Journal Article, Comment
 
   

MCSS v5.8 PRO. 0.346 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
28/04/2024